Nisa Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $179K | Buy |
609
+38
| +7% | +$10.8K | ﹤0.01% | 1289 |
|
|
2026
Q1 | $159K | Buy |
571
+21
| +4% | +$6.05K | ﹤0.01% | 1282 |
|
|
2025
Q4 | $167K | Hold |
550
| – | – | ﹤0.01% | 1275 |
|
|
2025
Q3 | $154K | Buy |
550
+393
| +250% | +$107K | ﹤0.01% | 1315 |
|
|
2025
Q2 | $37.9K | Sell |
157
-80
| -34% | -$18.9K | ﹤0.01% | 1671 |
|
|
2025
Q1 | $57.7K | Sell |
237
-299
| -56% | -$89.9K | ﹤0.01% | 1553 |
|
|
2024
Q4 | $176K | Sell |
536
-336
| -39% | -$114K | ﹤0.01% | 1328 |
|
|
2024
Q3 | $292K | Buy |
872
+322
| +59% | +$102K | ﹤0.01% | 1189 |
|
|
2024
Q2 | $150K | Sell |
550
-102
| -16% | -$29.7K | ﹤0.01% | 1379 |
|
|
2024
Q1 | $226K | Buy |
652
+108
| +20% | +$35.5K | ﹤0.01% | 1279 |
|
|
2023
Q4 | $176K | Sell |
544
-190
| -26% | -$59.6K | ﹤0.01% | 1304 |
|
|
2023
Q3 | $263K | Sell |
734
-6,090
| -89% | -$2.35M | ﹤0.01% | 1241 |
|
|
2023
Q2 | $2.59M | Buy |
6,824
+3,590
| +111% | +$1.46M | 0.02% | 605 |
|
|
2023
Q1 | $1.55M | Sell |
3,234
-941
| -23% | -$440K | 0.01% | 727 |
|
|
2022
Q4 | $1.76M | Sell |
4,175
-575
| -12% | -$232K | 0.01% | 769 |
|
|
2022
Q3 | $1.98M | Buy |
4,750
+3,278
| +223% | +$1.63M | 0.02% | 635 |
|
|
2022
Q2 | $729K | Buy |
1,472
+690
| +88% | +$359K | 0.01% | 931 |
|
|
2022
Q1 | $440K | Buy |
+782
| New | +$471K | ﹤0.01% | 1120 |
|
|
2021
Q4 | – | Sell |
-2,024
| Closed | -$1.51M | – | 2240 |
|
|
2021
Q3 | $1.51M | Sell |
2,024
-975
| -33% | -$730K | 0.01% | 782 |
|
|
2021
Q2 | $1.93M | Sell |
2,999
-100
| -3% | -$60.9K | 0.01% | 725 |
|
|
2021
Q1 | $1.77M | Hold |
3,099
| – | – | 0.01% | 753 |
|
|
2020
Q4 | $1.81M | Buy |
3,099
+310
| +11% | +$177K | 0.01% | 720 |
|
|
2020
Q3 | $1.44M | Sell |
2,789
-2,411
| -46% | -$1.22M | 0.01% | 691 |
|
|
2020
Q2 | $2.35M | Buy |
5,200
+364
| +8% | +$161K | 0.02% | 544 |
|
|
2020
Q1 | $1.7M | Buy |
4,836
+300
| +7% | +$110K | 0.02% | 572 |
|
|
2019
Q4 | $1.68M | Sell |
4,536
-314
| -6% | -$111K | 0.01% | 702 |
|
|
2019
Q3 | $1.61M | Buy |
4,850
+2,268
| +88% | +$740K | 0.01% | 712 |
|
|
2019
Q2 | $807K | Hold |
2,582
| – | – | 0.01% | 920 |
|
|
2019
Q1 | $789K | Buy |
2,582
+1,373
| +114% | +$371K | 0.01% | 918 |
|
|
2018
Q4 | $281K | Hold |
1,209
| – | – | ﹤0.01% | 1153 |
|
|
2018
Q3 | $378K | Buy |
1,209
+999
| +476% | +$310K | ﹤0.01% | 1170 |
|
|
2018
Q2 | $61K | Hold |
210
| – | – | ﹤0.01% | 1425 |
|
|
2018
Q1 | $53K | Hold |
210
| – | – | ﹤0.01% | 1415 |
|
|
2017
Q4 | $50K | Hold |
210
| – | – | ﹤0.01% | 1462 |
|
|
2017
Q3 | $47K | Sell |
210
-1,000
| -83% | -$225K | ﹤0.01% | 1453 |
|
|
2017
Q2 | $274K | Hold |
1,210
| – | – | ﹤0.01% | 1169 |
|
|
2017
Q1 | $241K | Sell |
1,210
-1,000
| -45% | -$193K | ﹤0.01% | 1208 |
|
|
2016
Q4 | $403K | Buy |
2,210
+2,000
| +952% | +$341K | ﹤0.01% | 1100 |
|
|
2016
Q3 | $34K | Sell |
210
-100
| -32% | -$15.2K | ﹤0.01% | 1475 |
|
|
2016
Q2 | $44K | Hold |
310
| – | – | ﹤0.01% | 1409 |
|
|
2016
Q1 | $42K | Buy |
+310
| New | +$40.7K | ﹤0.01% | 1416 |
|
|
2014
Q4 | – | Sell |
-3,310
| Closed | -$375K | – | 1283 |
|
|
2014
Q3 | $375K | Sell |
3,310
-700
| -17% | -$82.9K | 0.01% | 1090 |
|
|
2014
Q2 | $480K | Hold |
4,010
| – | – | 0.01% | 1042 |
|
|
2014
Q1 | $514K | Hold |
4,010
| – | – | 0.01% | 1022 |
|
|
2013
Q4 | $496K | Sell |
4,010
-1,500
| -27% | -$183K | 0.01% | 1029 |
|
|
2013
Q3 | $648K | Hold |
5,510
| – | – | 0.01% | 926 |
|
|
2013
Q2 | $618K | Buy |
+5,510
| New | +$646K | 0.01% | 927 |
|
Other funds holding BIO
AI
Nisa Investment Advisors's BIO Position: Q2 2026 in Review
Nisa Investment Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 6.7% in Q2 2026, buying an estimated $10.8K and bringing the position to 609 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.
Nisa Investment Advisors first reported a position in BIO in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.59M in Q2 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Nisa Investment Advisors held 609 shares of Bio-Rad Laboratories Class A worth $179K as of Q2 2026.
- Nisa Investment Advisors bought 38 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $10.8K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1289 holding.
- Nisa Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 47 quarters since.
- Nisa Investment Advisors's Bio-Rad Laboratories Class A position peaked at $2.59M in Q2 2023.
- 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.